U.S. Top High Growth Tech & AI Stocks - Spotless Financials

Palantir Technologies

Market Cap: US$419.7b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Procore Technologies

Market Cap: US$11.8b

Provides a cloud-based construction management platform and related products and services in the United States and internationally.

Duos Technologies Group

Market Cap: US$208.8m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

RenovoRx

Market Cap: US$34.8m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

ADMA Biologics

Market Cap: US$4.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Workday

Market Cap: US$57.0b

Provides enterprise cloud applications in the United States and internationally.

Circle Internet Group

Market Cap: US$20.3b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

Zscaler

Market Cap: US$38.6b

Operates as a cloud security company worldwide.

Cellebrite DI

Market Cap: US$4.4b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Sanmina

Market Cap: US$8.6b

Provides integrated manufacturing solutions, components, products and repair, logistics, and after-market services in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.

HubSpot

Market Cap: US$19.6b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

Precigen

Market Cap: US$1.3b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Kiniksa Pharmaceuticals International

Market Cap: US$3.1b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Viridian Therapeutics

Market Cap: US$3.0b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Atlassian

Market Cap: US$41.2b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

Invivyd

Market Cap: US$517.5m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

Rumble

Market Cap: US$2.6b

Operates video sharing platforms and cloud services in the United States, Canada, and internationally.

Zeta Global Holdings

Market Cap: US$4.4b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

Reddit

Market Cap: US$41.8b

Operates a digital community in the United States and internationally.

BioRestorative Therapies

Market Cap: US$9.6m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Semrush Holdings

Market Cap: US$1.8b

Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.

Krystal Biotech

Market Cap: US$6.3b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Cheetah Mobile

Market Cap: US$206.5m

Provides internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.

Roivant Sciences

Market Cap: US$14.4b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Interlink Electronics

Market Cap: US$56.5m

Provides sensors and printed electronics for use in human-machine interface (HMI) devices and internet-of-things solutions in the United States, Asia, the Middle East, Europe, and internationally.

SELLAS Life Sciences Group

Market Cap: US$247.8m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

MNTN

Market Cap: US$1.0b

Operates a technology platform that brings performance marketing to Connected TV.

Savara

Market Cap: US$1.5b

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Gyre Therapeutics

Market Cap: US$718.0m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

Trade Desk

Market Cap: US$19.0b

Operates as a technology company in the United States and internationally.

Arcturus Therapeutics Holdings

Market Cap: US$187.2m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Annexon

Market Cap: US$669.3m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Pure Storage

Market Cap: US$22.6b

Provides data storage and management technologies, products, and services in the United States and internationally.

Applied Optoelectronics

Market Cap: US$1.8b

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

Protagonist Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Aprea Therapeutics

Market Cap: US$6.5m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.